相关实验视频

Updated: May 7, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

对克拉里斯罗米辛不良事件信号的年龄分层分析:使用FDA不良事件报告系统进行不成比例分析

Haiyan Mai¹, Zhenpo Zhang², Yankun Liang²

¹The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

Therapeutic advances in drug safety

|January 6, 2025

概括

克拉利胺的安全性因年龄而异,儿童和成人有明显的不良事件 (AE). 这项研究分析了FAERS数据,以确定特定年龄的克拉里胺副作用,以便更好地进行临床管理.

科学领域:

药物监督药物监督药物监督
药品安全药品安全
临床药理学临床药理学

背景情况:

克拉里思罗米是一种被广泛处方的抗生素.
它在不同年龄的人口统计学中的安全性需要进一步调查.

研究的目的:

在各种年龄组中描述和分析与克拉里素相关的不良事件 (AE).
使用FDA不良事件报告系统 (FAERS) 数据库进行全面的安全分析.
为在不同人群中临床检测,预防和管理克拉里胺副作用提供参考.

主要方法:

在FAERS数据库中对AE报告的不成比例分析.
根据年龄组 (0-17,18-44,45-64,65岁) 的克拉里素AE报告的分层.
应用统计方法,包括报告赔率比率,比例报告比率,贝叶斯信心传播神经网络和多个马波桑缩小器.

主要成果:

分析了7319份克拉里胺AE报告.
根据年龄组确定了频繁的副作用:吐 (0-17岁),腹 (18-44岁),药物相互作用 (45-64岁) 和药物相互作用 (65岁以下).
检测到41个未在包装说明书中列出的显著AE信号,主要是精神病,皮肤和胃肠道疾病,有18个年龄特定的信号.

结论:

克拉利胺在不同年龄组中表现出不同的安全性.
儿科AE包括吐,过敏和呼吸障碍.
成年人经历更多的精神病性副作用,老年人需要谨慎,因为药物相互作用.

关键词:

公平的人是公平的.不良事件是不良事件.孩子们的孩子们的孩子们的孩子们克拉里斯罗米辛是什么意思克拉里斯罗米辛年长的老人老年人老年人.

更多相关视频

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

相关概念视频

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...